Latest news with #EndBrainCancerInitiative
Associated Press
08-05-2025
- Health
- Associated Press
The End Brain Cancer Initiative Hosts Free GBM Patient/Caregiver Educational Webinar for Brain Cancer Awareness Month
REDMOND, WA, UNITED STATES, May 8, 2025 / / -- Contact: Dellann Elliott Mydland, 425-785-8489, [email protected] The End Brain Cancer Initiative Hosts Free GBM Patient/Caregiver Educational Webinar for Brain Cancer Awareness Month In honor of Brain Cancer Awareness Month, the End Brain Cancer Initiative (EBCI) is hosting a free educational webinar for patients and caregivers on Friday, May 16, 2025 at 11 AM Pacific Time. The Know All Your Treatment Options (KAYTO) annual online event is designed specifically for members of the brain tumor, brain cancer, and metastasized brain tumor community to 'DIRECTLY CONNECT' with top specialists, doctors, and researchers in the field. Attendees will hear about advanced and FDA approved treatment options, clinical trials, devices, diagnostics, and more. The event is free to attend, but pre- registration is required. Registration is open at Thank you to presenting sponsors Telix Pharmaceuticals and Novocure for making this free patient disease educational event possible. This year's keynote speakers are Dr. John de Groot and Dr. Javier Villanueva-Meyer from the University of California, San Francisco (UCSF). The doctors will share updates and challenges in the diagnosis and management of Glioblastoma (GBM), as well as the role for advanced PET imaging and why it is important to GBM treatment. About Telix Pharmaceuticals Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Visit for further information. About Novocure Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure's commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, non-small cell lung cancer, malignant pleural mesothelioma and pleural mesothelioma. Novocure has several additional ongoing or completed clinical trials exploring the use of Tumor Treating Fields therapy in the treatment of glioblastoma, non- small cell lung cancer and pancreatic cancer. Visit for further information. About the End Brain Cancer Initiative To support/donate to the End Brain Cancer Initiative's increased access and health delivery for patients, mission, services and programs, please visit The End Brain Cancer Initiative (EBCI) is a 501(c)3 non-profit patient advocacy organization focused on disease education, awareness, outreach, increasing patient access and improving Standard of Care. The End Brain Cancer Initiative, formerly known as the Chris Elliott Fund (CEF), is dedicated to ensuring that all patients diagnosed with brain cancer, a brain tumor, or metastatic disease to the brain have equal access to advanced diagnostics, treatments, specialists, and clinical trial participation. We believe that IMMEDIATE ACCESS to these options provides this patient community with the best HOPE for survival and sustained quality of life. We partner with industry, patients, researchers, advocacy groups, medical teams, hospital networks and others to educate patients and their caregivers so they can have empowered conversations with their medical teams. Learn more about the End Brain Cancer Initiative at Dellann Elliott Mydland, End Brain Cancer Initiative, 425-785-8489, [email protected] Dellann Elliott Mydland End Brain Cancer Initiative +1 425-785-8489 [email protected] Visit us on social media: LinkedIn Instagram Facebook YouTube X Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Associated Press
18-03-2025
- Health
- Associated Press
Nominations Open for the End Brain Cancer Initiative's 2025 National Patient Disease Education Initiative and HOPE Award
Each May, for over a decade, the End Brain Cancer Initiative (EBCI) has presented the National HOPE Award to a brain cancer patient who deeply inspires us. REDMOND, WA, UNITED STATES, March 18, 2025 / / -- Nominations Open for the End Brain Cancer Initiative 's 2025 National Patient Disease Education Initiative and HOPE Award Redmond, WA (March 18, 2025) – Each May, for over a decade, the End Brain Cancer Initiative (EBCI) has presented the National HOPE Award to a brain cancer patient who deeply inspires us with their courage and story. EBCI established this patient disease education initiative and award to highlight exceptional people who have done exceptional things during their brain cancer journey, all while inspiring others. The deadline for submitting HOPE Award nominations is April 16th, 2025. To submit a nomination, people can visit Patrick 'Paddy' O'Donnell is the 2024 National HOPE Award recipient. Paddy was a 20-year-old collegiate ice hockey goaltender at the University of Utah when he had a seizure. He woke up in the Neuro ICU connected to tubes and monitors wondering what happened. A biopsy revealed he had Glioblastoma (GBM) and three tumors. Paddy was nominated by his mother, Anne O'Donnell. 'Paddy had to create his own HOPE and sought answers and second opinions about his treatment,' she said. 'End Brain Cancer Initiative was vital in our search, at the most critical time, availing us of options and direct contact with experts in the field whom Dellann knew personally.' The 2025 HOPE Award recipient will be announced during the End Brain Cancer Initiative's Know All Your Treatment Options (KAYTO25) online patient disease education event/webinar on May 16th, 2025. This free annual online event is designed specifically for members of the brain tumor, brain cancer, and metastasized brain tumor community to hear directly from top specialists, including researchers, in the field about advanced and FDA approved treatment options, clinical trials, devices, diagnostics, etc. that they may not have heard about and to 'DIRECTLY CONNECT' this patient population to many of these specialists. The event is free to attend due to corporate sponsorships, but pre-registration is required: About the End Brain Cancer Initiative To support/donate to the End Brain Cancer Initiative's increased access and health delivery for patients, mission, services and programs, please visit The End Brain Cancer Initiative (EBCI) is a 501(c)3 non-profit patient advocacy organization focused on disease education, awareness, outreach, increasing patient access and improving Standard of Care. The End Brain Cancer Initiative, formerly known as the Chris Elliott Fund (CEF), is dedicated to ensuring that all patients diagnosed with brain cancer, a brain tumor, or metastatic disease to the brain have equal access to advanced diagnostics, treatments, specialists, and clinical trial participation. We believe that IMMEDIATE ACCESS to these options provides this patient community with the best HOPE for survival and sustained quality of life. We partner with industry, patients, researchers, advocacy groups, medical teams, hospital networks and others to educate patients and their caregivers so they can have empowered conversations with their medical teams. Learn more about the End Brain Cancer Initiative at Dellann Elliott Mydland, End Brain Cancer Initiative, 425-785-8489, [email protected] ### Dellann Elliott Mydland End Brain Cancer Initiative +1 425-444-2215 X LinkedIn Instagram YouTube Legal Disclaimer:
